Brief report: Aldehyde dehydrogenase activity is a biomarker of primitive normal human mammary luminal cells

Stem Cells

Volumn 30, Issue 2, 2012, Pages 344-348

  Eirew, Peter ^a   Kannan, Nagarajan ^a   Knapp, David J H F ^a   Vaillant, François ^b,c   Emerman, Joanne T ^d   Lindeman, Geoffrey J ^b,c   Visvader, Jane E ^b,c   Eaves, Connie J ^a,d  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Breast cancer; Clonal assays; Progenitor cells; Tissue specific stem cells

Indexed keywords

ALDEHYDE DEHYDROGENASE; RETINOIC ACID; ALDEHYDE DEHYDROGENASE 1A3, HUMAN; ALDH1A1 PROTEIN, HUMAN; BIOLOGICAL MARKER;

ARTICLE; BREAST CELL; BREAST EPITHELIUM; CELL DIFFERENTIATION; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; HUMAN CELL; STEM CELL; ADULT; ADULT STEM CELL; CELL CULTURE; CYTOLOGY; ENZYMOLOGY; EPITHELIUM CELL; FEMALE; GENETIC TRANSCRIPTION; GENETICS; MAMMARY GLAND; METABOLISM; STROMA CELL;

ADULT; ADULT STEM CELLS; ALDEHYDE DEHYDROGENASE; BIOLOGICAL MARKERS; CELLS, CULTURED; EPITHELIAL CELLS; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; STROMAL CELLS; TRANSCRIPTION, GENETIC; YOUNG ADULT;

EID: 84856088648     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1001     Document Type: Article

References (23)

1. Moreb JS. Aldehyde dehydrogenase as a marker for stem cells. Curr Stem Cell Res Ther 2008;3:237-246.
2. Alison MR, Guppy NJ, Lim SM et al. Finding cancer stem cells: Are aldehyde dehydrogenases fit for purpose? J Pathol 2010;222:335-344.
3. Stingl J, Raouf A, Eirew P et al. Deciphering the mammary epithelial cell hierarchy. Cell Cycle 2006;5:1519-1522.
4. Eirew P, Stingl J, Raouf A et al. A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability. Nat Med 2008;14:1384-1389.
5. Lim E, Vaillant F, Wu D et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 2009;15:907-913.
6. Raouf A, Zhao Y, To K et al. Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Cell Stem Cell 2008;3:109-118.
7. Bachelard-Cascales E, Chapellier M, Delay E et al. The CD10 enzyme is a key player to identify and regulate human mammary stem cells. Stem Cells 2010;28:1081-1088.
8. Bloushtain-Qimron N, Yao J, Snyder EL et al. Cell type-specific DNA methylation patterns in the human breast. Proc Natl Acad Sci USA 2008;105:14076-14081.
9. Eirew P, Stingl J, Eaves CJ. Quantitation of human mammary epithelial stem cells with in vivo regenerative properties using a subrenal capsule xenotransplantation assay. Nat Protoc 2010;5:1945-1956.
10. Martignani E, Eirew P, Accornero P et al. Human milk protein production in xenografts of genetically engineered bovine mammary epithelial stem cells. PLoS One 2010;5:e13372.
11. Lim E, Wu D, Pal B et al. Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways. Breast Cancer Res 2010;12:R21.
12. Rexer BN, Zheng WL, Ong DE. Retinoic acid biosynthesis by normal human breast epithelium is via aldehyde dehydrogenase 6, absent in MCF-7 cells. Cancer Res 2001;61:7065-7070.
13. Asselin-Labat ML, Sutherland KD, Barker H et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 2007;9:201-209.
14. Hua S, Kittler R, White KP. Genomic antagonism between retinoic acid and estrogen signaling in breast cancer. Cell 2009;137:1259-1271.
15. Ginestier C, Wicinski J, Cervera N et al. Retinoid signaling regulates breast cancer stem cell differentiation. Cell Cycle 2009;8:3297-3302.
16. Charafe-Jauffret E, Ginestier C, Iovino F et al. Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res 2010;16:45-55.
17. Ginestier C, Hur MH, Charafe-Jauffret E et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007;1:555-567.
18. Marcato P, Dean CA, Pan D et al. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis. Stem Cells 2011;29:32-45.
19. Liu S, Ginestier C, Charafe-Jauffret E et al. BRCA1 regulates human mammary stem/progenitor cell fate. Proc Natl Acad Sci USA 2008;105:1680-1685.
20. Cozzio A, Passegue E, Ayton PM et al. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev 2003;17:3029-3035.
21. Huntly BJ, Shigematsu H, Deguchi K et al. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 2004;6:587-596.
22. Jamieson CH, Ailles LE, Dylla SJ et al. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 2004;351:657-667.
23. Wang Y, Krivtsov AV, Sinha AU et al. The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science 2010;327:1650-1653.